Brief: Liquidia Receives $50 Million From Healthcare Royalty Following First Commercial Sale Of YUTREPIA
23/06/2025 22:02
June 23 (Reuters) - Liquidia Corp LQDA.O: LIQUIDIA RECEIVES $50 MILLION FROM HEALTHCARE ROYALTY (HCRX) FOLLOWING FIRST COMMERCIAL SALE OF YUTREPIA™ LIQUIDIA CORP - UNDER TERMS OF HCR AGREEMENT, RECEIVES $175 MILLION OF $200 MILLION POTENTIAL FUNDING Source text: ID:nGNX54xXrv Further company coverage: LQDA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Liquidia
See all newsUS STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing